Skip to Content
Detecting Dementia image

Detecting Dementia


Chloe Reichel, featuring Carmel Shachar (Executive Director)
Harvard Law Today

Experts gathered this week to discuss the ethical, social, and legal implications of technological advancements that facilitate the early detection of dementia. “Detecting Dementia: Technology, Access, and the Law,…

New York Court… image

New York Court Officials Complete Rare Review of Cases Handled by Judge Forced Into Retirement by Dementia


Joe Sexton, quoting Francis Shen (Senior Fellow in Law and Applied Neuroscience)
ProPublica

In August, New York court officials made a sad and surprising announcement: ShawnDya Simpson, a 54-year-old judge, was retiring because of early onset Alzheimer’s disease. It was both…

Trump unveils… image

Trump unveils controversial drug price rules in a last-ditch attempt to fulfill campaign promise


Tami Luhby, featuring Rachel Sachs (Former Academic Fellow)
CNN

President Donald Trump unveiled two controversial rules on Friday aimed at reducing drug prices -- a last-ditch effort to fulfill a key 2016 promise that immediately sparked legal threats from the…

Trump pushes… image

Trump pushes last-minute drug pricing rules likely to face big legal challenges


Yasmeen Abutaleb, quoting Rachel Sachs (Former Academic Fellow)
The Washington Post

President Trump announced two sweeping drug pricing rules Friday that his administration is rushing to finalize before Inauguration Day to make good on his long-standing 2016 campaign promise to reduce what…

NIH fails to disclose… image

NIH fails to disclose enough details about drug licensing, watchdog report finds


Ed Silverman, featuring Jacob S. Sherkow (Former Edmond J. Safra Center and Petrie-Flom Center Fellow)
STAT News

Amid increasing debate over the cost of prescription drugs, a federal watchdog agency found the National Institutes of Health does not consider whether a medicine it discovered and licensed to…

Trump's recent… image

Trump’s recent drug pricing rules likely courtroom-bound, may up costs


Donna Young, quoting Rachel Sachs (Former Academic Fellow)
S&P Global

Two drug pricing rules President Donald Trump is finalizing Nov. 20 are likely to end up in court or jettisoned by the incoming Biden administration, policy and legal experts said. Trump…

Trump administration… image

Trump administration pushes last-ditch plans to lower drug prices


Jonathan Gardner and Ned Pagliarulo, quoting Rachel Sachs (Former Academic Fellow)
BioPharma Dive

The Trump administration on Friday put in motion two last-ditch efforts to deliver on the president's repeated promises to lower prescription drug costs in the U.S., announcing a…

A Final Try by Trump… image

A Final Try by Trump to Cut Drug Prices May Stumble in Court


Margot Sanger-Katz and Noah Weiland, quoting Rachel Sachs (Former Academic Fellow)
New York Times

Health officials on Friday finalized a policy that would base the price Medicare pays for certain drugs on the lowest price paid in some other developed nations. It is the…

JAMA Research Letter… image

JAMA Research Letter Finds the Share of Physicians Receiving Industry Payments Decreases


Thomas Sullivan, quoting Carmel Shachar (Executive Director)
Policy & Medicine

A recent research letter published in JAMA stated that since the 2014 launch of the Open Payments database, the share of physicians who received industry payments has decreased but the total…

Better Marketing Data… image

Better Marketing Data Can Lead to Better Patient Care


Jessica Kim Cohen, quoting Mason Marks (Edmond J. Safra Center and Petrie-Flom Center Fellow)
Modern Healthcare